Erin Guest

1.5k total citations
34 papers, 551 citations indexed

About

Erin Guest is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Erin Guest has authored 34 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 12 papers in Pediatrics, Perinatology and Child Health and 11 papers in Molecular Biology. Recurrent topics in Erin Guest's work include Acute Lymphoblastic Leukemia research (17 papers), Childhood Cancer Survivors' Quality of Life (11 papers) and Acute Myeloid Leukemia Research (9 papers). Erin Guest is often cited by papers focused on Acute Lymphoblastic Leukemia research (17 papers), Childhood Cancer Survivors' Quality of Life (11 papers) and Acute Myeloid Leukemia Research (9 papers). Erin Guest collaborates with scholars based in United States, Canada and Denmark. Erin Guest's co-authors include Chengqi Lin, Ali Shilatifard, Man Mohan, Zhuojuan Luo, Laurence Florens, Stacy A. Marshall, Michael P. Washburn, Alexander S. Garrett, Selene K. Swanson and Alan S. Gamis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature reviews. Cancer.

In The Last Decade

Erin Guest

28 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin Guest United States 12 353 147 107 76 75 34 551
Agata Pastorczak Poland 13 217 0.6× 136 0.9× 210 2.0× 103 1.4× 96 1.3× 57 510
Matthew T. Witkowski United States 13 241 0.7× 151 1.0× 103 1.0× 31 0.4× 149 2.0× 27 493
Chunlin Zhou China 11 253 0.7× 203 1.4× 92 0.9× 13 0.2× 103 1.4× 69 461
Lene Olesen Denmark 11 378 1.1× 353 2.4× 142 1.3× 17 0.2× 54 0.7× 13 535
Cosimo Cumbo Italy 15 254 0.7× 279 1.9× 100 0.9× 15 0.2× 77 1.0× 45 566
Klaudia Hettinger Austria 5 139 0.4× 55 0.4× 69 0.6× 23 0.3× 54 0.7× 7 246
Chutima Kumkhaek United States 13 160 0.5× 205 1.4× 46 0.4× 59 0.8× 21 0.3× 25 457
Sajad Khazal United States 10 66 0.2× 151 1.0× 122 1.1× 41 0.5× 138 1.8× 33 322
Nayera Hamdy Egypt 11 142 0.4× 56 0.4× 52 0.5× 24 0.3× 88 1.2× 25 322
Alexander Platz Germany 7 121 0.3× 156 1.1× 29 0.3× 37 0.5× 79 1.1× 9 357

Countries citing papers authored by Erin Guest

Since Specialization
Citations

This map shows the geographic impact of Erin Guest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Guest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Guest more than expected).

Fields of papers citing papers by Erin Guest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Guest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Guest. The network helps show where Erin Guest may publish in the future.

Co-authorship network of co-authors of Erin Guest

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Guest. A scholar is included among the top collaborators of Erin Guest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Guest. Erin Guest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
John, Samuel, Kevin J. Curran, Amy K. Keating, et al.. (2025). Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry. Blood Advances. 9(20). 5249–5262.
2.
Li, Amanda M., Catherine Aftandilian, Susan I. Colace, et al.. (2024). A Retrospective Study of Inotuzumab Ozogamicin in Individuals with Down Syndrome and B-Cell Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 4204–4204.
3.
Schmitt, Anthony D., Kristin Sikkink, Atif Ahmed, et al.. (2024). Evaluation of Hi-C Sequencing for Detection of Gene Fusions in Hematologic and Solid Tumor Pediatric Cancer Samples. Cancers. 16(17). 2936–2936.
4.
Yoo, Byunggil, Warren Cheung, Chengpeng Bi, et al.. (2023). Abstract 243: Long-read sequencing of pediatric cancer genomes identifies multiple clinically relevant variants. Cancer Research. 83(7_Supplement). 243–243. 1 indexed citations
5.
Kocewiak, Łukasz, et al.. (2023). Active filtering trial to reduce harmonic voltage distortion in an offshore wind power plant. IET conference proceedings.. 2023(20). 394–399. 3 indexed citations
6.
Huynh, Van, Anurag K. Agrawal, Christine L. Phillips, et al.. (2023). Asparaginase-Associated Toxicities and Hypersensitivity Reactions in Pediatric and Adolescent Down Syndrome Patients with Acute Lymphoblastic Leukemia or Lymphoma. Blood. 142(Supplement 1). 5809–5809.
7.
Kairalla, John A., ZoAnn E. Dreyer, Andrew J. Carroll, et al.. (2023). Minimal residual disease predicts outcomes in KMT2A‐rearranged but not KMT2A‐germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631. Pediatric Blood & Cancer. 70(9). e30467–e30467. 1 indexed citations
8.
9.
Jensen, Kim H., et al.. (2023). Grid-forming control methods for weakly connected offshore WPPs. IET conference proceedings.. 2023(20). 246–253. 3 indexed citations
10.
Guest, Erin, John A. Kairalla, Joanne M. Hilden, et al.. (2022). Outstanding outcomes in infants with <i>KMT2A</i>-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial. Haematologica. 107(5). 1205–1208. 12 indexed citations
11.
Pollard, Jessica A., Erin Guest, Todd A. Alonzo, et al.. (2021). Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A -Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531. Journal of Clinical Oncology. 39(28). 3149–3160. 57 indexed citations
12.
August, Keith J., et al.. (2019). Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib. Pediatric Blood & Cancer. 67(3). e28062–e28062. 19 indexed citations
13.
August, Keith J., Joy M. Fulbright, Jay M. Portnoy, et al.. (2019). Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma. Pediatric Blood & Cancer. 67(1). 15 indexed citations
14.
Sauvé, Laura, David A. Goldfarb, Erin Guest, et al.. (2019). Risk factors for cerebrospinal fluid shunt infections during an outbreak: a case–control study. Journal of Hospital Infection. 105(1). 78–82.
15.
DeSimone, Robert A., Gary D. Myers, Erin Guest, & Patricia A. Shi. (2018). Combined heparin/acid citrate dextrose solution A anticoagulation in the Optia continuous mononuclear cell protocol for pediatric lymphocyte apheresis. Journal of Clinical Apheresis. 34(4). 487–489. 6 indexed citations
16.
Raman, Sripriya, et al.. (2017). Parental Perceptions of Obesity and Obesity Risk Associated With Childhood Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 39(5). 370–375. 4 indexed citations
17.
Kingsmore, Stephen F., Josh E Petrikin, Laurel K. Willig, & Erin Guest. (2015). Emergency medical genomes: a breakthrough application of precision medicine. Genome Medicine. 7(1). 82–82. 25 indexed citations
18.
Fulbright, Joy M., et al.. (2014). Childhood Cancer for the Primary Care Physician. Primary Care Clinics in Office Practice. 42(1). 43–55. 11 indexed citations
19.
20.
Mohan, Man, Chengqi Lin, Erin Guest, & Ali Shilatifard. (2010). Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis. Nature reviews. Cancer. 10(10). 721–728. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agata Pastorczak Breakdown of academic impact, for papers by Matthew T. Witkowski Breakdown of academic impact, for papers by Chunlin Zhou Breakdown of academic impact, for papers by Lene Olesen Breakdown of academic impact, for papers by Cosimo Cumbo Breakdown of academic impact, for papers by Klaudia Hettinger Breakdown of academic impact, for papers by Chutima Kumkhaek Breakdown of academic impact, for papers by Sajad Khazal Breakdown of academic impact, for papers by Nayera Hamdy Breakdown of academic impact, for papers by Alexander Platz
Rankless by CCL
2026